Hawaii Pacific Neuroscience

Honolulu, Hawaii 96817

13 studies enrolling now · 49 studies all time

What they study most

Adjustment Disorder, Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease Dementia, Alzheimers Disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Dentatorubral-Pallidoluysian Atrophy, Developmental and Epileptic Encephalopathies, Developmental and Epileptic Encephalopathy, Dravet Syndrome, Drug Resistant Epilepsy, Early Alzheimer's Disease

Studies at this site

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses — Recruiting now
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease — Recruiting now
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis — Recruiting now
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis — Recruiting now
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — Recruiting now
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Recruiting now
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG) — Recruiting now
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care — Recruiting now
An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis — Enrolling by invitation
Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation — Running, not enrolling
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity. — Completed
Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures — Completed
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
Cenobamate Open-Label Extension Study for YKP3089C025 — Completed
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease — Completed
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD — Running, not enrolling
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures — Stopped early
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
Lu AF28996 in Participants With Parkinson's Disease (PD) — Completed
Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy — Completed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy — Running, not enrolling
A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) — Completed
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations — Running, not enrolling
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
Intermediate-Size Expanded Access Protocol (EAP) for LP352 — Available (expanded access)
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. — Completed
Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies — Completed
A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy — Stopped early
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures — Completed
A Study of TAK-994 in Adults With Narcolepsy — Stopped early
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension — Completed
ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures — Withdrawn before enrolling
Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients — Completed
Microdose Pharmacokinetic Study of PRX-P4-003 In Healthy Volunteers — Completed
Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures. — Completed
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures — Completed
Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy — Completed
A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures — Completed
Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease — Completed
Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease. — Stopped early